Etodolac injection in post operative orthopedic pain.
- Conditions
- Health Condition 1: null- Post Operative Orthopedic pain
- Registration Number
- CTRI/2010/091/000437
- Lead Sponsor
- Ipca Laboratories Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
1. Male and female patients aged 18 to 65 years
2. Satisfactory medical assessment with no clinically significant or relevant abnormalities except for study related disease condition
3. Patients who are undergoing any of the following elective orthopedic surgeries such asknee arthroscopy, repair of femoral neck fracture, repair of trochanteric fracture, repair of ankle fracture (bimalleolar type), repair of femoral or tibial fracture, fixation for foot injuries, fixation for pelvic fractures and repair of patella fracture.
4.Patients with the post operative orthopedic pain of at least 5cm on the 10cm pain intensity Visual Analogue Scale and at least a score of 2 on 4 point verbal rating scale
5. Patients fulfilling the American Society of Anesthesiology (ASA) I or II or III criteria for post operative orthopedic pain
6. The subject must understand and be able, willing and likely to fully comply with study procedures and ready to give written informed consent
1. Patients having complication during or after surgical procedure
2. Patients with abnormal renal and liver function
3. Patients with significant medical illness
4. Patient having any concomitant medication, which may interact with action of study drugs.
5. Patients with known history of hypersensitivity to NSAIDS or diclofenac or any other ingredient of the study medication or other similar drugs of same chemical class
7. Pregnant or lactating women
8. Women of childbearing potential not practicing contraception
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean fall in pain intensityTimepoint: At 15 min, 30 min, 1 hr and then 2, 4, 6, 8, 12, 16, 20 and 24 hours;Mean fall in pain intensityTimepoint: At 15 min, 30 min, 1 hr and then 2, 4, 6, 8, 12, 16, 20 and 24 hours
- Secondary Outcome Measures
Name Time Method Safety and toleability of study medicationTimepoint: throughout the duration of study;Total doses of rescue medication consumedTimepoint: In the entire study duration